Vacc-iNTS | Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa

Summary
Invasive non-typhoidal Salmonellosis (iNTS) is an important emerging Neglected Infectious Disease in resource-poor settings of sub-Saharan Africa (sSA). No vaccine is currently available. Estimated 263,000 iNTS deaths per year in
Resources Show all and search (18)
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/815439
Start date: 01-10-2019
End date: 30-09-2024
Total budget - Public funding: - 6 871 188,00 Euro
Cordis data

Original description

Invasive non-typhoidal Salmonellosis (iNTS) is an important emerging Neglected Infectious Disease in resource-poor settings of sub-Saharan Africa (sSA). No vaccine is currently available. Estimated 263,000 iNTS deaths per year in

Status

SIGNED

Call topic

SC1-BHC-15-2018

Update Date

26-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.3. Treating and managing disease
H2020-EU.3.1.3.0. Cross-cutting call topics
H2020-SC1-2018-Two-Stage-RTD
SC1-BHC-15-2018 New anti-infective agents for prevention and/or treatment of neglected infectious diseases (NID)
Search
Search on Google
Search on Bing
Search on DuckDuckGo
Organisations
Show all (15)
Powered by Chris Decubber BV